To know or not to know: Ethical issues related to early diagnosis of Alzheimer's disease

International Journal of Alzheimer's Disease

Volumn , Issue , 2010, Pages

  Mattsson, Niklas ^a   Brax, David ^b   Zetterberg, Henrik ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE VACCINE;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL COMPETENCE; CLINICAL DECISION MAKING; CLINICAL TRIAL; COGNITIVE DEFECT; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DRUG SAFETY; EARLY DIAGNOSIS; HUMAN; HYPOTHESIS; INFORMED CONSENT; LUMBAR PUNCTURE; MEDICAL ETHICS; MENINGOENCEPHALITIS; MILD COGNITIVE IMPAIRMENT; PATIENT DECISION MAKING; PERSONAL AUTONOMY; PERSONALITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; UNCERTAINTY;

EID: 77955939164     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2010/841941     Document Type: Review

References (22)

1. Mattsson N., Zetterberg H., Future screening for incipient Alzheimer's diseasethe influence of prevalence on test performance European Neurology 2009 62 4 200 203
2. Lynge E., Antilla A., Arbyn M., Segnan N., Ronco G., What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination European Journal of Cancer 2009 45 15 2714 2721
3. Schrder F. H., PSA screeninga review of recent studies European Journal of Cancer 2009 45 1 402 404
4. Hansson O., Zetterberg H., Buchhave P., Londos E., Blennow K., Minthon L., Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Lancet Neurology 2006 5 3 228 234
5. Mattsson N., Zetterberg H., Hansson O., Andreasen N., Parnetti L., Jonsson M., Herukka S.-K., Van Der Flier W. M., Blankenstein M. A., Ewers M., Rich K., Kaiser E., Verbeek M., Tsolaki M., Mulugeta E., Rosn E., Aarsland D., Jelle Visser P., Schrder J., Marcusson J., De Leon M., Hampel H., Scheltens P., Pirttil T., Wallin A., Eriksdotter Jnhagen M., Minthon L., Winblad B., Blennow K., CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment Journal of the American Medical Association 2009 302 4 385 393
6. Frisoni G. B., The prevalence of apoE-epsilon 4 in Alzheimer's disease is age dependent Journal of Neurology, Neurosurgery Psychiatry 1998 65 1 103 106
7. Andreasen N., Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice Archives of Neurology 2001 58 3 373 379
8. Blennow K., Wallin A., Hager O., Low frequency of post-lumbar puncture headache in demented patients Acta Neurologica Scandinavica 1993 88 3 221 223
9. Peskind E. R., Riekse R., Quinn J. F., Kaye J., Clark C. M., Farlow M. R., Decarli C., Chabal C., Vavrek D., Raskind M. A., Galasko D., Safety and acceptability of the research lumbar puncture Alzheimer Disease and Associated Disorders 2005 19 4 220 225
10. Draper B., Peisah C., Snowdon J., Brodaty H., Early dementia diagnosis and the risk of suicide and euthanasia Alzheimer's and Dementia 2010 6 1 75 82
11. Kaduszkiewicz H., Bachmann C., van den Bussche H., Telling the truth in dementia-Do attitude and approach of general practitioners and specialists differ? Patient Education and Counseling 2008 70 2 220 226
12. Karnieli-Miller O., Werner P., Aharon-Peretz J., Eidelman S., Dilemmas in the (un)veiling of the diagnosis of Alzheimer's disease: walking an ethical and professional tight rope Patient Education and Counseling 2007 67 3 307 314
13. Bamford C., Lamont S., Eccles M., Robinson L., May C., Bond J., Disclosing a diagnosis of dementia: a systematic review International Journal of Geriatric Psychiatry 2004 19 2 151 169
14. Smith A. P., Beattie B. L., Disclosing a diagnosis of Alzheimer's disease: patient and family experiences Canadian Journal of Neurological Sciences 2001 28 supplement 1 S67 S71
15. van der Cammen T. J. M., Croes E. A., Dermaut B., De Jager M.-C., Cruts M., Van Broeckhoven C., Van Duijn C. M., Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease Journal of the American Geriatrics Society 2004 52 12 2110 2113
16. Bayer A. J., Bullock R., Jones R. W., Wilkinson D., Paterson K. R., Jenkins L., Millais S. B., Donoghue S., Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD Neurology 2005 64 1 94 101
17. Martin A. J., Marottoli R., O'Neill D., Driving assessment for maintaining mobility and safety in drivers with dementia Cochrane Database of Systematic Reviews 2009 1
18. Porteri C., Galluzzi S., Geroldi C., Frisoni G. B., Diagnosis disclosure of prodromal Alzheimer disease-ethical analysis of two cases Canadian Journal of Neurological Sciences 2010 37 1 67 75
19. Locke J., Nidditch P. H., An Essay Concerning Human Understanding 1975 Oxford, UK Clarendon Press
20. Parfit D., Reasons and Persons 1984 Oxford, UK Clarendon Press
21. Egonsson D., Some comments on the substituted judgement standard Medicine, Healthcare and Philosophy 2010 13 1 33 40
22. Huizing A. R., Berghmans R. L. P., Widdershoven G. A. M., Verhey F. R. J., Do caregivers' experiences correspond with the concerns raised in the literature? Ethical issues relating to anti-dementia drugs International Journal of Geriatric Psychiatry 2006 21 9 869 875